Samuel García Pérez

12PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesRespiratory diseasesRheumatology and arthritisMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 04, 2023
Amphiphilic Phosphorus Dendrons Associated with Anti-inflammatory siRNA Reduce Symptoms in Murine Collagen-Induced Arthritis.

Zhibo Yu, Nicolas Tsapis, François Fay

|Nov 18, 2022
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients.

Sara Martínez-Ramos, Carlos Rafael-Vidal, Beatriz Malvar-Fernández

|Feb 15, 2022
Monocytes and Macrophages in Spondyloarthritis: Functional Roles and Effects of Current Therapies.

Sara Martínez-Ramos, Carlos Rafael-Vidal, José M Pego-Reigosa

|Jan 10, 2022
Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.

Ana Igea, Tiago Carvalheiro, Beatriz Malvar-Fernández

|Oct 23, 2021
Distinctive CD26 Expression on CD4 T-Cell Subsets.

Oscar J Cordero, Carlos Rafael-Vidal, Rubén Varela-Calviño

|Jan 30, 2021
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.

Carlos Rafael-Vidal, Irene Altabás, Nair Pérez

Pageof 2

Frequent Collaborators

4 joint publications

Tiago Carvalheiro

4 joint publications

Carlos Rafael-Vidal

2 joint publications

Ana P Lopes

2 joint publications

Jose M Pego-Reigosa